Uehara Akiko, Okamoto Yuhji, Nishitarumizu Kazutaka, Uto Tadashi, Kubota Ryuhji, Johnosono Manabu, Eiraku Nobutaka, Arimura Kimiyoshi, Osame Mitsuhiro
Third Department of Internal Medicine, Kagoshima University School of Medicine.
Rinsho Shinkeigaku. 2002 Mar;42(3):237-9.
A patient with exanthem and fever showed progressive disturbance of consciousness and flaccid quadriplegia predominantly in the lower extremities. Antibiotics, aciclovir, high-dose methylprednisolone (1 g/day for 3 consecutive days) and IVIG (400 mg/kg/day for 5 consecutive days) were not effective. Nerve conduction study and SEP in the lower extremities showed peripheral and central conduction block. EEG showed irregular sharp and slow waves predominantly in the left hemisphere. ABR and SEP in the upper extremities were normal. Consecutive studies of cranial and spinal MRIs showed no abnormalities. A diagnosis of acute disseminated encephalomyelitis (ADEM) was made. We started administration of ultra-high-dose methylprednisolone (5.4 mg/kg/h for 47 hours), the dose for acute spinal cord injury based on the randomized controlled trial of The Third National Acute Spinal Cord Injury Study in the USA. After this, she regained consciousness and the quadriplegia improved. The abnormalities in the electrophysiological studies also normalized. It is thought that the neuroprotective mechanism of ultra-high-dose methylprednisolone could be attributed to its inhibition of lipid peroxidation, secondary, ischemia, energy failure and so on. If the usual treatment is not effective for severe encephalomyelitis cases, we can consider the administration of ultra-high-dose methylprednisolone as one of the new treatment options.
一名患有皮疹和发热的患者出现意识进行性障碍以及以下肢为主的弛缓性四肢瘫。抗生素、阿昔洛韦、大剂量甲泼尼龙(连续3天,每日1 g)和静脉注射免疫球蛋白(连续5天,每日400 mg/kg)均无效。下肢神经传导研究和体感诱发电位显示周围和中枢传导阻滞。脑电图显示主要在左半球出现不规则的尖波和慢波。上肢听觉脑干诱发电位和体感诱发电位正常。连续的头颅和脊髓磁共振成像检查未显示异常。诊断为急性播散性脑脊髓炎(ADEM)。我们开始给予超高剂量甲泼尼龙(按照美国第三次全国急性脊髓损伤研究的随机对照试验中急性脊髓损伤的剂量,5.4 mg/kg/h,持续47小时)。此后,她恢复了意识,四肢瘫有所改善。电生理研究中的异常也恢复正常。超高剂量甲泼尼龙的神经保护机制被认为可能归因于其对脂质过氧化、继发性缺血、能量衰竭等的抑制作用。如果常规治疗对重症脑脊髓炎病例无效,我们可以考虑将给予超高剂量甲泼尼龙作为新的治疗选择之一。